Aalborg Hospital / Aarhus University Hospital
Aalborg, Jutland, 9000, Denmark
NCT Number: NCT00613912
Depression is the most common psychiatric disorder.
* 3-5% of a given population has major depression. * Less than 50% of the depressed in Denmark are diagnosed with major depression. * 25-50% of the depressed have a relative with major depression-underlying brain pathology?
The purpose of this study is to use MRI to evaluate cerebral morphology and function in ambulant patients with major depression
Looking for future studies?
Notify Me20 year–65 year
All sexes
Observational
Aalborg, Jutland, 9000, Denmark
Previous studies within major depression, have often included hospitalized patients with severe symptoms and imaging have been performed with PET and SPECT, which uses ionizing radiation. This study focus on ambulant patients(with or without medication/ECT treatment), to find patients in an earlier stage. Cerebral perfusion with the MR sequence Arterial Spin Labelling, concentrations of different metabolites with MR spectroscopy and brain volumetry with BRAVO 3D T1 ax will be performed.
MR protocol: T2 sag, T2 FLAIR ax, ASL ax, MRS and 3D T1 ax. Scan time 45 min.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: 3 Tesla GE Scanner HDx
Time frame: 6 months from first MRI in each patient
University of Aarhus
Other
Advanced MRI at 3T for the Evaluation of Ambulant Patients With Major Depression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05680727
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT07258485
Depressive Disorder, Depressive Disorder, Major
Phoenix, Arizona, United States
View Trial DetailsNCT06558344
Depressive Disorder, Depressive Disorder, Major
Bellflower, California, United States
View Trial DetailsNCT04533529
Depressive Disorder, Depressive Disorder, Major
Anaheim, California, United States
View Trial Details